BSE filing, NSE: SANDUPHQ. Summary written from the filing by ALFA Finder's alert engine.
Sandu Pharmaceuticals Ltd: key numbers
- Share price
- ₹35.95
- Market cap
- ₹34.73 Cr
- Revenue (annual)
- ₹69.93 Cr
- Net profit (annual)
- ₹1.77 Cr
- P/E (TTM)
- 14.3×Sector 45.9×
- Promoter holding
- 37.79%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sandu Pharmaceuticals Ltd
All →Sandu Pharmaceuticals Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals intimated that Non-Executive Independent Director Dr Neeti Madan Kapre has changed her name to Dr Neeti Gupta after marriage. The DIN, designation and directorship remain unchanged.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals Limited has issued a reminder to physical shareholders regarding the mandatory submission of PAN and KYC details. This compliance follow-up aims to facilitate electronic dividend payments.
Sandu Pharmaceuticals Management Change
Sandu Pharmaceuticals appointed Dr. Neeti Madan Kapre as director and Dave & Dave as statutory auditor, while announcing other board and auditor tenure changes.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals has appointed M/s. Dave & Dave as Statutory Auditors for a five-year term, following the tenure expiry of the previous auditors.
Sandu Pharmaceuticals Annual General Meeting
Sandu Pharmaceuticals Limited held its 41st Annual General Meeting on September 11, 2026, via video conferencing to transact ordinary and special business items.
Other legal & regulatory announcements
All →DIC India Legal & Regulatory
DIC India's GST demand for FY 2021-22 was reduced on appeal to Rs.1.29 lakh from Rs.4.68 lakh. The company is evaluating the order.
- Value
- ₹0.01 Cr
Blue Star Legal & Regulatory
Blue Star's Dubai Court of Appeal dismissed WJT's application to annul the arbitration award in the company's favour. WJT may still appeal the award.
- Value
- ₹461.7 Cr
Mahalaxmi Rubtech Legal & Regulatory
Mahalaxmi Rubtech was fined by BSE and NSE for delayed XBRL voting results. The fines of Rs.11,800 each have been paid and the results uploaded.
- Value
- ₹0.00 Cr
FDC Legal & Regulatory
FDC received tax orders giving an aggregate refund of Rs.37.22 Crore for AY 2014-15 and AY 2012-13. The refund follows favourable CIT(A) orders on the company's appeals.
- Value
- ₹37.22 Cr
LG Electronics India Legal & Regulatory
LG Electronics India received an Order-in-Original from Customs reclassifying imports and imposing a ₹40 lakh redemption fine and ₹5 lakh penalty. A differential duty demand of ₹61.30 lakh was also confirmed.
- Value
- ₹0.45 Cr
LG Electronics India Legal & Regulatory
LG Electronics India received a customs Order-in-Original imposing duty, fine and penalty totalling Rs 1.06 Crore. The company is evaluating the order.
- Value
- ₹1.06 Cr